A gene therapy mystery? GenSight blasted as 1st PhIII eye study ends in an intriguing failure – Endpoints News
Endpoints News |
A gene therapy mystery? GenSight blasted as 1st PhIII eye study ends in an intriguing failure
Endpoints News The mystery: The other eyes that received a sham therapy did just as well with their eyesight. Exactly as well. That makes the Phase III study a failure, and rather than stay to try and solve the mystery, investors bailed, driving down the EuroNext … |
